InvestorsHub Logo
Followers 51
Posts 8993
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Monday, 10/22/2018 4:08:02 AM

Monday, October 22, 2018 4:08:02 AM

Post# of 2495
'Neutrolin has both fast track and QIDP status. There is a significant unmet medical need to prevent infections in hemodialysis patients with central venous catheters.'

10.5 years of US exclusivity of a rare win win. Hospitals save billions and lives while we make billions. This is an ideal set up.

"We have an exciting near-term potential opportunity with our Phase 3 asset in Neutrolin and look forward to the FDA meeting in quarter four 2018."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRMD News